Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study

Atherosclerosis

Volumn 148, Issue 1, 2000, Pages 95-100

  Gaw, Allan ^a   Brown, E Ann ^a   Docherty, Gillian ^b   Ford, Ian ^b  

^a 4th Fl Qu Elizabeth Bldg Roy I ^*  (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cholesterol; Lipoprotein(a); WOSCOPS

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; RISK FACTOR; TECHNIQUE; TURBIDIMETRY;

CASE-CONTROL STUDIES; CHOLESTEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORECASTING; HUMANS; IMMUNOLOGIC TECHNIQUES; LIPOPROTEIN(A); MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; REFERENCE VALUES; VASCULAR DISEASES;

EID: 0033991181     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00259-2     Document Type: Article

References (20)

1. Albers J.J., Adolphson J.L., Hazzard W.R. Radio-immunoassay of human plasma Lp(a) lipoprotein. J. Lipid Res. 18:1977;331.
2. Sandholzer C., Saha N., Kark J.D., Rees A., Jaross W., Dieplinger H. et al. Apo(a) isoforms predict risk for coronary heart disease. Arterioscler. Thromb. 12:1992;1214.
3. Rhoads G.G., Dahlen G.H., Berg K., Morton N.E., Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J. Am. Med. Assoc. 256:1986;2540.
4. Bostom A.G., Cupples L.A., Jenner J.L. et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J. Am. Med. Assoc. 276:1996;544.
5. Armstrong V.W., Cremer P., Eberle E. et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: Dependence on serum LDL levels. Atherosclerosis. 62:1986;249.
6. Dahlén G.H. Lipoprotein(a), atherosclerosis and thrombosis. Prog. Lipid Res. 30:1991;189.
7. Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle-aged men. Br. Med. J. 301:1990;1248.
8. Jauhiainen M., Koskinen P., Ehnholm C., Frick M.H., Mänttäri M., Manninen V., Huttunen J.K. Lipoprotein(a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants. Atherosclerosis. 89:1991;59.
9. Nieminen M.S., Mattila K.J., Aalto-Setälä K., Kuusi T., Kontula K., Kauppinen-Mäkelin R. et al. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler. Thromb. 12:1992;58.
10. Ridker P.M., Hennekens C.H., Stampfer M.J. A prospective study of lipoprotein(a) and the risk of myocardial infarction. J. Am. Med. Assoc. 270:1993;2195.
11. Gaw A. Lipoprotein(a) and risk of myocardial infarction (Letter). J. Am. Med. Assoc. 271:1994;1077.
12. Schaefer E.J., Lamon-Fava S., Jenner J.L., Mcnamara J.R., Ordovas J.M., Davis E. et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid research clinics coronary primary prevention trial. J. Am. Med. Assoc. 271:1994;999.
13. Cremer P., Nagel D., Labrot B., Mann H., Muche R., Elster H. et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur. J. Clin. Invest. 24:1994;444.
14. Seman L.J., Jenner J.L., McNamara J.R., Schaefer E.J. Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction. Clin. Chem. 94:1994;2351.
15. WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Study. Am J Cardiol 1995; 76:485.
16. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., Macfarlane P.W. et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Eng. J. Med. 333:1995;1301.
17. Labeur C., Michiels G., Bury J., Usher D.C., Rosseneu M. Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin. Chem. 35:1989;1380-1384.
18. Gaw A., Gourlay C.W.D., Brown E.A., Bell M.A. Evaluation of a new automated latex agglutination assay for lipoprotein(a): comparison with a manual ELISA. Clin. Chim. Acta. 261:1997;175.
19. Gaw A., Boerwinkle E., Cohen J.C., Hobbs H.H. Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnic groups-evidence for no common 'null' allele at the apo(a) locus. J. Clin. Invest. 93:1994;2526.
20. Kronenberg F., Lobentanz E.M., Konig P., Utermann G., Dieplinger H. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J. Lipid Res. 35:1994;1318.